154 related articles for article (PubMed ID: 29960019)
1. Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.
Lin SJ; Chin YT; Ho Y; Chou SY; Sh Yang YC; Nana AW; Su KW; Lim YT; Wang K; Lee SY; Shih YJ; Chen YR; Whang-Peng J; Davis PJ; Lin HY; Fu E
Food Chem Toxicol; 2018 Oct; 120():1-11. PubMed ID: 29960019
[TBL] [Abstract][Full Text] [Related]
2. Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.
Lin HY; Chin YT; Nana AW; Shih YJ; Lai HY; Tang HY; Leinung M; Mousa SA; Davis PJ
Steroids; 2016 Oct; 114():59-67. PubMed ID: 27221508
[TBL] [Abstract][Full Text] [Related]
3. NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer.
Huang TY; Chang TC; Chin YT; Pan YS; Chang WJ; Liu FC; Hastuti ED; Chiu SJ; Wang SH; Changou CA; Li ZL; Chen YR; Chu HR; Shih YJ; Cheng RH; Wu A; Lin HY; Wang K; Whang-Peng J; Mousa SA; Davis PJ
Cells; 2020 Aug; 9(8):. PubMed ID: 32756527
[TBL] [Abstract][Full Text] [Related]
4. NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.
Ho Y; Wu CY; Chin YT; Li ZL; Pan YS; Huang TY; Su PY; Lee SY; Crawford DR; Su KW; Chiu HC; Shih YJ; Changou CA; Yang YSH; Whang-Peng J; Chen YR; Lin HY; Mousa SA; Davis PJ; Wang K
Food Chem Toxicol; 2020 Feb; 136():111092. PubMed ID: 31883986
[TBL] [Abstract][Full Text] [Related]
5. The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.
Lee YS; Chin YT; Yang YSH; Wei PL; Wu HC; Shih A; Lu YT; Pedersen JZ; Incerpi S; Liu LF; Lin HY; Davis PJ
Steroids; 2016 Jul; 111():63-70. PubMed ID: 26980146
[TBL] [Abstract][Full Text] [Related]
6. Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation.
Chang TC; Chin YT; Nana AW; Wang SH; Liao YM; Chen YR; Shih YJ; Changou CA; Yang YS; Wang K; Whang-Peng J; Wang LS; Stain SC; Shih A; Lin HY; Wu CH; Davis PJ
Horm Cancer; 2018 Dec; 9(6):420-432. PubMed ID: 30187356
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells.
Chen YR; Chen YS; Chin YT; Li ZL; Shih YJ; Yang YSH; ChangOu CA; Su PY; Wang SH; Wu YH; Chiu HC; Lee SY; Liu LF; Whang-Peng J; Lin HY; Mousa SA; Davis PJ; Wang K
Food Chem Toxicol; 2019 Oct; 132():110693. PubMed ID: 31336132
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac.
Sudha T; Bharali DJ; Yalcin M; Darwish NH; Coskun MD; Keating KA; Lin HY; Davis PJ; Mousa SA
Nanomedicine (Lond); 2017 Feb; 12(3):195-205. PubMed ID: 28102776
[TBL] [Abstract][Full Text] [Related]
9. Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages.
Jiang C; Yuan F; Wang J; Wu L
Immunobiology; 2017 Apr; 222(4):651-657. PubMed ID: 28017495
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Activities of Hesperidin via Suppression of Up-Regulated Programmed Death-Ligand 1 Expression in Oral Cancer Cells.
Wudtiwai B; Makeudom A; Krisanaprakornkit S; Pothacharoen P; Kongtawelert P
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500779
[TBL] [Abstract][Full Text] [Related]
11. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
Wu Q; Zhao Y; Sun Y; Yan X; Wang P
Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
[TBL] [Abstract][Full Text] [Related]
12. Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1.
Ishibashi M; Tamura H; Sunakawa M; Kondo-Onodera A; Okuyama N; Hamada Y; Moriya K; Choi I; Tamada K; Inokuchi K
Cancer Immunol Res; 2016 Sep; 4(9):779-88. PubMed ID: 27440711
[TBL] [Abstract][Full Text] [Related]
13. Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway.
Su KW; Lin HY; Chiu HC; Shen SY; ChangOu CA; Crawford DR; Yang YSH; Shih YJ; Li ZL; Huang HM; Whang-Peng J; Ho Y; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36231010
[TBL] [Abstract][Full Text] [Related]
14. CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity.
Straub M; Drecoll E; Pfarr N; Weichert W; Langer R; Hapfelmeier A; Götz C; Wolff KD; Kolk A; Specht K
Oncotarget; 2016 Mar; 7(11):12024-34. PubMed ID: 26918453
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.
Sudha T; Bharali DJ; Sell S; Darwish NHE; Davis PJ; Mousa SA
Horm Cancer; 2017 Jun; 8(3):157-165. PubMed ID: 28396979
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin-specific peptidase 9, X-linked in oral squamous cell carcinoma.
Jingjing W; Wenzheng G; Donghua W; Guangyu H; Aiping Z; Wenjuan W
Cancer Med; 2018 Aug; 7(8):4004-4011. PubMed ID: 29992764
[TBL] [Abstract][Full Text] [Related]
17. An update of knowledge on PD-L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives.
Lenouvel D; González-Moles MÁ; Talbaoui A; Ramos-García P; González-Ruiz L; Ruiz-Ávila I; Gil-Montoya JA
Oral Dis; 2020 Apr; 26(3):511-526. PubMed ID: 30866171
[TBL] [Abstract][Full Text] [Related]
18. Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells.
Chin YT; Wei PL; Ho Y; Nana AW; Changou CA; Chen YR; Yang YS; Hsieh MT; Hercbergs A; Davis PJ; Shih YJ; Lin HY
Endocr Relat Cancer; 2018 May; 25(5):533-545. PubMed ID: 29555649
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
Sudha T; Bharali DJ; Yalcin M; Darwish NH; Debreli Coskun M; Keating KA; Lin HY; Davis PJ; Mousa SA
Int J Nanomedicine; 2017; 12():1305-1315. PubMed ID: 28243091
[TBL] [Abstract][Full Text] [Related]
20. Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models.
Lanzel EA; Paula Gomez Hernandez M; Bates AM; Treinen CN; Starman EE; Fischer CL; Parashar D; Guthmiller JM; Johnson GK; Abbasi T; Vali S; Brogden KA
Cancer Immunol Immunother; 2016 Dec; 65(12):1511-1522. PubMed ID: 27688163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
